Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a Neisseria meningitidis serogroup B vaccine in healthy infants starting at 2 months; the trial is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Meningococcal group B vaccine (Neisseria meningitidis serogroup B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Meningitis, Meningococcal | Phase 4 | Status: ACTIVE_NOT_RECRUITING